Fujian South Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PACLITAXEL (SEMI-SYNTHETIC) USP NON STERILE BULK DRUG SUBSTANCE, with a corresponding US DMF Number 25822.
Remarkably, this DMF maintains an Active status since its submission on February 23, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 30, 2021, and payment made on June 09, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II